Palmetto Veracyte Bladder Cancer Test Receives Medicare Coverage The patient must be a candidate for multiple potential treatments with varying levels of intensity or multiple therapies. Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests Under the local coverage determination, tests to help identify patients who may benefit from a prostate biopsy would be covered under certain conditions. Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection Under the policy, covered tests must provide information about active rejection status or cellular or antibody-mediated rejection status. Local Coverage Determinations Roundup: Castle Bio A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors. CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests The company's AlloSure Kidney test received coverage, along with its AlloSure Heart test when used with the firm's AlloMap test. Nov 6, 2020 Medicare Administrative Contractor CGS Aligns Coverage for Melanoma Risk Stratification Tests Nov 2, 2020 GenomeWeb Index Up 5 Percent in October as Favorable Earnings Reports Bolster Shaky Market Oct 28, 2020 Strata Oncology Receives Medicare Coverage for NGS Test Oct 22, 2020 Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences Oct 8, 2020 Castle Bio Receives Expanded Medicare Coverage for Melanoma Test Oct 1, 2020 CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto Sep 25, 2020 Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test Sep 25, 2020 Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD Sep 10, 2020 Two Medicare Contractors Align Coverage for MRD Testing With Palmetto Sep 3, 2020 Natera Receives LCD From Palmetto for Signatera MRD Test in Colorectal Cancer Patients Jul 28, 2020 NeoGenomics Expects Q3 Revenue Growth as it Expands Liquid Biopsy Offerings, COVID-19 Testing Premium Jul 2, 2020 Noridian Aligns With Palmetto on Single-Gene, Multi-Gene PGx Test Coverage Jun 19, 2020 Local Coverage Determinations Roundup: Razor Genomics, Guardant Health Jun 11, 2020 Palmetto Providing Limited Coverage for Single-Gene, Multi-Gene PGx Tests May 26, 2020 NeoGenomics, Inivata Partner to Commercialize Lung Cancer Liquid Biopsy Test Apr 30, 2020 Oncocyte NSCLC Test Gets Local Coverage Determination From Palmetto Mar 12, 2020 Noridian Issues Final LCD for Decipher Biosciences Prostate Cancer Test Feb 28, 2020 Local Coverage Determinations Roundup: Natera, DermTech Jan 30, 2020 MolDx Finalizes Expanded Coverage for Liquid Biopsies Jan 8, 2020 Adaptive Biotechnologies Gains Expanded Medicare Coverage for ClonoSeq Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.